BamSEC and AlphaSense Join Forces
Learn More

Pluri Inc.

NASDAQ: PLUR    
Share price (12/20/24): $4.82    
Market cap (12/20/24): $26.8 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.35
from 10-K 18 pages Amended and Restated Employment Agreement Duly Made and Executed on the Date Set Forth in Appendix 1 by and Between Pluri Biotech Ltd. Company Number 513371666 (Hereinafter the “Company”) and Liat Zalts I.D. 41706953
12/34/56
EX-10.2
from 8-K 17 pages Amended and Restated Technology License Agreement
12/34/56
EX-10.1
from 8-K 23 pages Share Purchase Agreement
12/34/56
EX-10.7
from 10-Q ~1 page Amendment #1 to the Consulting Agreement
12/34/56
EX-10.6
from 10-Q 2 pages Amendment to the Amended and Restated Employment Agreement
12/34/56
EX-10.5
from 10-Q 2 pages Amendment to the Amended and Restated Employment Agreement
12/34/56
EX-10.4
from 10-Q 1 page Summary of Directors Ongoing Compensation
12/34/56
EX-10.3
from 10-Q 7 pages Pluri Inc. Restricted Stock Units Agreement Made as Of
12/34/56
EX-10.2
from 10-Q 7 pages Pluri Inc. Restricted Stock Units Agreement Made as Of
12/34/56
EX-10.1
from 10-Q 7 pages Pluri Inc. Restricted Stock Units Agreement Made as Of
12/34/56
EX-10.2
from 10-Q 11 pages Consulting Agreement
12/34/56
EX-10.2
from 8-K 20 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 10-Q 19 pages Technology License Agreement
12/34/56
EX-10.1
from 10-Q 21 pages Share Purchase Agreement
12/34/56
EX-10.2
from 10-Q ~5 pages English Summary of Supplement to Lease Agreement Dated December 31, 2021
12/34/56
EX-10.1
from 8-K 12 pages Consulting Agreement
12/34/56
EX-10.30
from 10-K 2 pages Agreement
12/34/56
EX-10.29
from 10-K 2 pages Agreement
12/34/56
EX-10.28
from 10-K 2 pages Agreement
12/34/56
EX-10.20
from 10-K 7 pages Pluristem Therapeutics Inc. Restricted Stock Units Agreement Made as Of
12/34/56